Search

everythinglearnresearchcommunity

for

Search:↓

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Transplant success has improved with better immunosuppressive drugs and donor matching.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Nanoparticle systems make cancer treatment less toxic.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Sex hormones affect brain injury differently in males and females.

Diphencyprone helped most patients with alopecia areata regrow some hair.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Cancer treatments often cause skin, nail, and hair problems.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

A 6-year-old girl with alopecia universalis regrew most of her hair after treatment with simvastatin/ezetimibe, minoxidil, and prednisolone.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Both treatments helped hair regrowth in alopecia areata, with isopropanol being better tolerated.

Some treatments work better for different types of hair loss, and nutrients like iron and L-lysine are important for preventing hair loss.

A tailored treatment improved a Pomeranian dog's skin and hair issues caused by a vaccine.

New treatments for atopic dermatitis and alopecia areata have been developed using a targeted approach.